Explorer
Less dependence on oxygen, know about DRDO's anti-COVID drug
"In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by Day-3 in comparison to SoC, indicating an early relief from Oxygen therapy/dependence," the ministry stated.
A similar trend was observed in patients aged more than 65 years.
On May 1, 2021, the DCGI granted permission for Emergency Use of this drug as adjunct therapy in moderate to severe COVID-19 patients.
India
Crime: Reward Increased to ₹1 Lakh for Accused in Ghazipur Vineet Murder Case
Breaking: US–Israel Rift Deepens Amid Allegations of Intelligence Tensions Over Iran Policy
Accident: Chef’s Statement Reveals Possible Electrical Fault Behind Blaze
Politics: Dhirendra Shastri Raises Concerns Over ‘Friendship Jihad’ in Rajkot Speech
Geopolitics: Unverified Claims Circulate About Iran’s Leadership and Supreme Leader Succession
View More
Top Headlines
India
Eggs Hurled At TMC Leader Madan Mitra's Car In West Bengal: Watch
India
OPINION | Expanding Footprint Of India’s BrahMos
World
Wanted To Keep 7.5-Carat Diamond Gifted By PM Modi, But Was Too Expensive: Jill Biden
World
US Weighs Using Frozen Iranian Assets To Fund Gulf Reconstruction: Report
Trending News
